TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is the most common malignancy of the liver. Genomic analysis is conducted to identify genetic alterations in driver genes which are all druggable targets for cancer therapy. In the present study, we performed an exome sequencing of 45 driver genes in 100 paired samples...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncol Rep
Main Authors: Ye, Song, Zhao, Xin-Yi, Hu, Xiao-Ge, Li, Tang, Xu, Qiu-Ran, Yang, Huan-Ming, Huang, Dong-Sheng, Yang, Liu
Format: Artigo
Jezik:Inglês
Izdano: D.A. Spandidos 2017
Teme:
Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5367355/
https://ncbi.nlm.nih.gov/pubmed/28350084
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2017.5494
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki